Matthew Silva to Clinical Trials as Topic
This is a "connection" page, showing publications Matthew Silva has written about Clinical Trials as Topic.
Connection Strength
0.145
-
Silva MA, Donovan JL, Gandhi PJ, Volturo GA. Platelet inhibitors in non-ST-segment elevation acute coronary syndromes and percutaneous coronary intervention: glycoprotein IIb/IIIa inhibitors, clopidogrel, or both? Vasc Health Risk Manag. 2006; 2(1):39-48.
Score: 0.051
-
Silva MA, Gandhi PJ. Selection of glycoprotein IIb/IIIa inhibitors for upstream use in patients with diabetes experiencing unstable angina or non-ST segment elevation myocardial infarction. What have we learned in the last 10 years? J Clin Pharm Ther. 2004 Dec; 29(6):497-510.
Score: 0.047
-
Chan KY, Boucher ES, Gandhi PJ, Silva MA. HMG-CoA reductase inhibitors for lowering elevated levels of C-reactive protein. Am J Health Syst Pharm. 2004 Aug 15; 61(16):1676-81.
Score: 0.047